Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mark W Lowdell

Showing results (21-30 of 74) with videos related to

Pageof 8
Sort By:
British Journal of Haematology|July 9, 2002
Alloantigen-specific T-cell depletion in a major histocompatibility complex fully mismatched murine model provides effective graft-versus-host disease prophylaxis in the presence of lymphoid engraftmentMickey B C Koh, H Grant Prentice, Marguerite Corbo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 22, 2006
Tumor-primed human natural killer cells lyse NK-resistant tumor targets: evidence of a two-stage process in resting NK cell activationJanet North, Ismail Bakhsh, Chloe Marden, et al.
Regenerative Medicine|November 29, 2014
Operating RegenMed: development of better in-theater strategies for handling tissue-engineered organs and tissuesJonathan M Fishman, Justin C R Wormald, Mark W Lowdell, et al.
Materials Science & Engineering. C, Materials for Biological Applications|September 7, 2018
Silsesquioxane polymer as a potential scaffold for laryngeal reconstructionNazia Mehrban, James Bowen, Angela Tait, et al.
British Journal of Haematology|June 13, 2002
Evidence that continued remission in patients treated for acute leukaemia is dependent upon autologous natural killer cellsMark W Lowdell, Rose Craston, David Samuel, et al.
Cytotherapy|June 5, 2016
Cryopreservation of human mesenchymal stromal cells expressing TRAIL for human anti-cancer therapyZhengqiang Yuan, Sofia Da Silva Lourenco, Elizabeth K Sage, et al.
Blood|June 26, 2010
The role of Vδ2-negative γδ T cells during cytomegalovirus reactivation in recipients of allogeneic stem cell transplantationAndrea Knight, Alejandro J Madrigal, Sarah Grace, et al.
Tissue Engineering|September 14, 2006
Human mesenchymal stem cells induce T cell anergy and downregulate T cell allo-responses via the TH2 pathway: relevance to tissue engineering human heart valvesPuspa Batten, Padmini Sarathchandra, Joseph W Antoniw, et al.
Expert Opinion on Biological Therapy|August 8, 2014
Airway tissue engineering: an updateJonathan M Fishman, Katherine Wiles, Mark W Lowdell, et al.
Scientific Reports|May 19, 2024
Autologous bone marrow derived mesenchymal stem cells are safe for the treatment of Achilles tendinopathyAndrew J Goldberg, Lorenzo Masci, Paul O'Donnell, et al.
Pageof 8

Showing results (21-30 of 74) with videos related to

Sort By:
Pageof 8
British Journal of Haematology|July 9, 2002
Alloantigen-specific T-cell depletion in a major histocompatibility complex fully mismatched murine model provides effective graft-versus-host disease prophylaxis in the presence of lymphoid engraftmentMickey B C Koh, H Grant Prentice, Marguerite Corbo, et al.
Journal of Immunology (Baltimore, Md. : 1950)|December 22, 2006
Tumor-primed human natural killer cells lyse NK-resistant tumor targets: evidence of a two-stage process in resting NK cell activationJanet North, Ismail Bakhsh, Chloe Marden, et al.
Regenerative Medicine|November 29, 2014
Operating RegenMed: development of better in-theater strategies for handling tissue-engineered organs and tissuesJonathan M Fishman, Justin C R Wormald, Mark W Lowdell, et al.
Materials Science & Engineering. C, Materials for Biological Applications|September 7, 2018
Silsesquioxane polymer as a potential scaffold for laryngeal reconstructionNazia Mehrban, James Bowen, Angela Tait, et al.
British Journal of Haematology|June 13, 2002
Evidence that continued remission in patients treated for acute leukaemia is dependent upon autologous natural killer cellsMark W Lowdell, Rose Craston, David Samuel, et al.
Cytotherapy|June 5, 2016
Cryopreservation of human mesenchymal stromal cells expressing TRAIL for human anti-cancer therapyZhengqiang Yuan, Sofia Da Silva Lourenco, Elizabeth K Sage, et al.
Blood|June 26, 2010
The role of Vδ2-negative γδ T cells during cytomegalovirus reactivation in recipients of allogeneic stem cell transplantationAndrea Knight, Alejandro J Madrigal, Sarah Grace, et al.
Tissue Engineering|September 14, 2006
Human mesenchymal stem cells induce T cell anergy and downregulate T cell allo-responses via the TH2 pathway: relevance to tissue engineering human heart valvesPuspa Batten, Padmini Sarathchandra, Joseph W Antoniw, et al.
Expert Opinion on Biological Therapy|August 8, 2014
Airway tissue engineering: an updateJonathan M Fishman, Katherine Wiles, Mark W Lowdell, et al.
Scientific Reports|May 19, 2024
Autologous bone marrow derived mesenchymal stem cells are safe for the treatment of Achilles tendinopathyAndrew J Goldberg, Lorenzo Masci, Paul O'Donnell, et al.
Pageof 8